Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology

R Altman, B Bosch, K Brune, P Patrignani, C Young - Drugs, 2015 - Springer
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) of the phenylacetic acid class
with anti-inflammatory, analgesic, and antipyretic properties. Contrary to the action of many …

In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media

C Markopoulos, CJ Andreas, M Vertzoni… - European Journal of …, 2015 - Elsevier
Background Biorelevant media for evaluation of dosage form performance in the
gastrointestinal lumen were first introduced in the late 1990s. Since then, a variety of …

Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study

D Shep, C Khanwelkar, P Gade, S Karad - Trials, 2019 - Springer
Background The purpose of this study was to compare the efficacy and safety of curcumin
with those of diclofenac in the treatment of knee osteoarthritis (OA). Methods In this …

Quality by design approach for formulation development: a case study of dispersible tablets

NA Charoo, AAA Shamsher, AS Zidan… - International journal of …, 2012 - Elsevier
The focus of the current investigations was to apply quality by design (QbD) approach to the
development of dispersible tablets. Critical material and process parameters are linked to …

Biowaiver monographs for immediate release solid oral dosage forms: furosemide

GE Granero, MR Longhi, MJ Mora… - Journal of …, 2010 - Elsevier
Literature and new experimental data relevant to the decision to allow a waiver of in vivo
bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage …

Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions

K Thelen, K Coboeken, S Willmann, R Burghaus… - Journal of …, 2011 - Elsevier
To enable more precise prediction of oral drug absorption, an existing physiologically based
absorption model was revised. The revised model reflects detailed knowledge of human …

Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form

E Jantratid, V De Maio, E Ronda, V Mattavelli… - European Journal of …, 2009 - Elsevier
In vitro biorelevant dissolution tests enabling the prediction of in vivo performance of an oral
modified-release (MR) dosage form were developed in this study. In vitro dissolution of MR …

Enhancement of water solubility of poorly water-soluble drugs by new biocompatible N-acetyl amino acid N-alkyl cholinium-based ionic liquids

AR Jesus, MRC Soromenho, LR Raposo… - European Journal of …, 2019 - Elsevier
The major challenge of the pharmaceutical industry is to find potential solvents for poorly
water-soluble drug molecules. Ionic liquids (ILs) have attracted this industry as (co-) solvents …

Modeling and comparison of release profiles: Effect of the dissolution method

S Cascone - European Journal of Pharmaceutical Sciences, 2017 - Elsevier
During the last decades, the study of the in vitro dissolution of pharmaceuticals has been
strongly encouraged by the FDA in order to determine its relationship with the in vivo …

Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen

IE Shohin, JI Kulinich, GV Ramenskaya… - Journal of …, 2012 - Elsevier
Literature and experimental data relevant to the decision to allow a waiver of in vivo
bioequivalence (BE) testing for the approval of immediate‐release (IR) solid oral dosage …